Is running good for anxiety during perimenopause?

Running is one of the most evidence-backed interventions for anxiety, and perimenopausal anxiety specifically responds well to it. The hormonal shifts of perimenopause, particularly the erratic fluctuations in estrogen and progesterone, disrupt the neurotransmitter systems that regulate mood and the stress response. Running acts directly on those systems in ways that complement and sometimes rival pharmaceutical approaches.

Aerobic exercise increases the production and availability of serotonin, GABA, and brain-derived neurotrophic factor (BDNF). GABA in particular is significant because declining progesterone during perimenopause reduces the brain's natural calming signals. Progesterone's metabolite allopregnanolone acts on GABA receptors to produce calming effects, and as progesterone falls, this calming mechanism weakens. Exercise partially compensates by upregulating GABA activity independently. Multiple randomized controlled trials have found that regular aerobic exercise reduces anxiety symptoms in clinical populations, with effect sizes comparable to low-dose anxiolytic medication.

Running also has the advantage of engaging the body's stress response system in a controlled, recoverable way. Every run is a mild stressor that the body adapts to and recovers from. Over time, this repeated exposure trains the nervous system to recover more efficiently from stress in general, which reduces baseline anxiety and improves resilience to triggers. This is a form of stress inoculation that builds genuine anxiety tolerance over weeks and months.

Cortisol regulation is another key mechanism. Perimenopausal women often have heightened cortisol reactivity, meaning their bodies release more cortisol in response to normal daily stressors. Regular aerobic exercise lowers resting cortisol and improves the speed of cortisol recovery after stress. The net effect is a calmer physiological baseline from which anxiety is less severe and triggers are less disruptive.

Endocannabinoid release during running is part of what produces the runner's high. Endocannabinoids reduce anxiety, promote calm, and lower pain sensitivity. They persist in the bloodstream for one to two hours after exercise ends, providing a meaningful post-run window of anxiety relief that complements the serotonin and GABA effects. For women who experience free-floating anxiety throughout the day, this post-run window of calm is one of running's most immediate and appreciated benefits.

Heart rate variability (HRV) is a physiological marker of autonomic nervous system resilience and anxiety regulation capacity. Low HRV is associated with anxiety disorders and chronically activated stress responses. Running consistently improves HRV over time, meaning the nervous system becomes more adaptable and recovers faster from perturbations. This improved regulatory capacity directly supports anxiety management and reduces the hypervigilance that many perimenopausal women experience as their hormonal environment shifts.

BDNF produced during aerobic exercise strengthens the prefrontal cortex's regulatory control over the amygdala, the brain region most associated with fear and anxiety responses. During perimenopause, estrogen decline reduces the prefrontal dampening of amygdala reactivity, leading to exaggerated fear responses and anxiety that feels disproportionate to circumstances. Running's BDNF-mediated support of prefrontal-amygdala regulation helps restore more appropriate emotional modulation, which reduces anxiety reactivity over weeks of consistent training.

Intensity matters for anxiety. Very high-intensity running, particularly intervals at maximum effort, can temporarily raise anxiety by spiking adrenaline and cortisol during the session. Women who already have significant anxiety often do better starting with moderate-intensity steady-state running, where they can maintain a conversation, before adding intervals. Over time, as fitness improves, higher intensity becomes more tolerable and eventually beneficial.

The rhythmic, repetitive nature of running also has a meditative quality that can interrupt anxious thought loops. Many runners describe a mental quieting that sets in around 20 to 30 minutes into a run, which is related to endocannabinoid release and the focus-narrowing effect of sustained physical effort. This cognitive quieting is itself therapeutic, giving the overactive perimenopausal mind regular breaks from the rumination cycle that sustains anxiety.

Consistency matters more than duration. Three to four runs per week of 20 to 40 minutes each produces better anxiety outcomes than occasional longer runs. The neurochemical benefits accumulate gradually, and gaps of more than two to three days allow anxiety-related neurotransmitter patterns to drift back toward baseline.

Tracking your symptoms over time with an app like PeriPlan can help you spot patterns between your running schedule and anxiety severity throughout your hormonal cycle.

When to talk to your doctor: If anxiety is severe, includes panic attacks, or is significantly interfering with your daily functioning, please seek evaluation. Perimenopause-related anxiety is treatable with hormone therapy, therapy, and medication, and these should not be delayed in favor of exercise alone.

This content is for informational purposes only and does not replace medical advice. Always consult your healthcare provider about your specific situation.